| Filed On | Filing |
|---|---|
| 19 Oct 2026 |
Form 4: Lynch Thomas P., See Remarks
Received 2,000 shares by exercise or conversion ($17.3K) |
| 16 Oct 2026 |
Form 4: Atay Oguzhan, Director
Received 3,183 shares by exercise or conversion ($8.91K) · Sold 5,850 shares ($574K) · Received 5,150 shares by exercise or conversion ($14.4K) · 1 more |
| 15 Oct 2026 | 144 |
| 14 Oct 2026 |
Form 4: Atay Oguzhan, Director
Received 16,667 shares by exercise or conversion ($46.7K) · Sold 19,334 shares ($1.82M) |
| 14 Oct 2026 | 144 |
| 14 Oct 2026 | 144 |
| 13 Oct 2026 |
Form 4: Lynch Thomas P., See Remarks
Received 8,000 shares by exercise or conversion ($69.2K) |
| 13 Oct 2026 | 144 |
| 13 Oct 2026 | 144 |
| 07 Oct 2026 |
Form 4: Tsao David, Director
Received 20,000 shares by exercise or conversion ($56K) · Sold 20,000 shares ($2.16M) |
| 07 Oct 2026 |
Form 4: ten Bosch John Roderick, SVP of Laboratory Operations
Sold 2,834 shares ($298K) |
| 05 Oct 2026 | 144 |
| 05 Oct 2026 | 144 |
| 05 Oct 2026 | 144 |
| 30 Sep 2026 |
Form 4: Atay Oguzhan, Director
Received 8,333 shares by exercise or conversion ($23.3K) · Sold 10,999 shares ($1.33M) |
| 28 Sep 2026 |
Form 4: Tsao David, Director
Received 3,333 shares by exercise or conversion ($9.33K) · Sold 3,333 shares ($417K) |
| 28 Sep 2026 |
Form 4: ten Bosch John Roderick, SVP of Laboratory Operations
Sold 1,416 shares ($170K) |
| 28 Sep 2026 | 144 |
| 28 Sep 2026 | 144 |
| 24 Sep 2026 | 144 |
Loading...